Elastography in Liver Cell Failure
Evaluation of Splenic Stiffness in Liver Cell Failure Patients:Role of Elastography
1 other identifier
observational
77
1 country
1
Brief Summary
- 1.evaluation of degree of spleen stiffness in liver cell failure patient by elastography.
- 2.correlation of degree of spleen stiffness and patient outcome
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedFirst Posted
Study publicly available on registry
October 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
October 18, 2023
October 1, 2023
3.2 years
September 29, 2023
October 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of splenic stiffness in liver cell failure patients: role of elastography
1. evaluation of degree of spleen stiffness in liver cell failure patient by elastography. 2. correlation of degree of spleen stiffness and patient outcome
4 years
Study Arms (1)
patients with liver cell failure
patients with liver cell failure and any complications
Interventions
evaluation of degree of spleen stiffness in liver cell failure patient by elastography.
Eligibility Criteria
any patient has any clinical picture for liver cell failure
You may qualify if:
- Age above 18 years. 2-patients with liver cell failure (hepatic encephalopathy, hematemesis, ascites, hepatocellular carcinoma) 3- patient height , Weight
You may not qualify if:
- patients who refuse to contribute in this study. 2- Age below 18 years. 3-pregnancy and breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, Egypt
Related Publications (2)
Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun. 2022 May;6(5):950-964. doi: 10.1002/hep4.1855. Epub 2021 Dec 14.
PMID: 34904404RESULTYiyi M, Xiaoqin Q, Lei Z. Spleen Stiffness on Magnetic Resonance Elastography for the Detection of Portal Hypertension: A Systematic Review and Meta-Analysis. Iran J Public Health. 2022 Sep;51(9):1925-1935. doi: 10.18502/ijph.v51i9.10548.
PMID: 36743372RESULT
Biospecimen
Samples not dependent on DNA of the patients
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Lecturer
Study Record Dates
First Submitted
September 29, 2023
First Posted
October 18, 2023
Study Start
October 1, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
October 18, 2023
Record last verified: 2023-10